The “4th World Congress on Endocrinology & Diabetes”, which is scheduled for February13-14, 2025 to address recent developments and transformations in Diabetes research and development, is the conference series' most eagerly awaited physical event. Two days of scientific keynote presentations, special sessions, poster presentations, networking, and discussions will be covered throughout this conference.
Endocrinology Conference is pleased to invite you to this physical Endocrinology Congress 2025 event.
With the help of another 1000 scientific societies, Conference Series LLC organizes 300+ conferences, 500+ workshops, and 200+ symposiums on general practice, pharmaceuticals, healthcare, cardiac diagnosis workshops, cardiology conferences, endocrine series, and many other technologies each year in the United States, Europe generally, Asia, the Middle East, Australia, and the United Kingdom. It Publishes 500 open-access journals with editorial boards made up of more than 30000 well-known celebrities and world-class academics.
-
Get fresh knowledge about their area of specialization from the meeting's speakers through conversation, presentations and abstracts.
-
Have face-to-face meetings with authors, presenters, and specialists to discuss novel concepts.
-
Continuing education units.
-
This might mark a turning point in their professional lives.
-
Maintain and enhance your sense of self.
-
Disseminate your research findings to investors and specialists throughout the world. Through introductions, governance conversations, panel discussions, and workshops, we explore each issue in its entirety, from large-scale global concerns to techniques to strategic problems.
-
Participants will increase the accessibility of guides to a hub of leaders and consultants, as well as broaden perception through system evaluation and management at conferences.
For abstract submission
For registration
-
Endocrinologists
-
Diabetologist
-
General Practitioners
-
Nurses specializing in diabetes care
-
Dietitians and nutritionists
-
Professors and researchers from academic institutions with a focus on diabetes studies
-
Pediatrist
-
Professionals involved in developing diabetes medications and devices
-
Representatives from pharmaceutical and medical device companies
-
Diabetes educators
-
Trainers involved in diabetes prevention and management programs
-
Health department officials
-
Representatives from relevant government agencies involved in healthcare and public health policies related to diabetes
Endocrinology drugs market is poised to grow by over 6% during the forecast period. The report on endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The Endocrine market in Italy is estimated to reach more than 7% between 2022 and 2027. \Diabetes will affect around 9.9% of the Austria population by 2023. Unhealthy, a poor diet, and a physical inactivity all are included to rise a newly diagnosed Type 1 and Type 2 diabetes cases.
This study identifies the research in novel dosage formulations and drug delivery systems as one of the prime reasons driving the endocrinology drugs market growth during the next few years.
The report on endocrinology drugs market covers the following areas:
Endocrinology drugs market sizing
Endocrinology drugs market forecast
Endocrinology drugs market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Endocrinology drugs market vendors that include Acerus Pharmaceuticals Corp., Beta Cell NV, Eli Lilly and Co., GlaxoSmithKline Plc, Ipsen Pharma SA, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., and Sanofi SA.
The report contains a comprehensive market and vendor landscape in addition to an analysis the vendors of key.
Endocrinology Congress-2023 report
Lexis Conference hosted the event “2nd world congress Endocrinology and diabetes” in March 13-14, 2022 held in Austria during October 18-19, 2023. The conferences were organized with a focus on the themes “Recent Advancements and Developments in Diabetes and Endocrinology.” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering. For more details
